Patients who underwent heart transplant with or without bridge to transplant left ventricular assist device therapy had superior 5-year survival vs. those with LVAD destination therapy when matched on ...

New York, NY - Clinical outcomes for the sickest HF patients are far better among those given a left-ventricular assist device (LVAD) as compared with those maintained on inotropic drugs, whether they ...

Since the first LVAD was placed in 1984, more than 6000 of the devices have been placed worldwide (O.H. Frazier, personal communication, January 2002). As LVAD therapy makes the transition from ...

CHICAGO – An attempt to employ stem cells to rescue patients from left ventricular assist devices (LVAD) failed to provide benefit to the patients in an National Institutes of Health-supported ...

Patients with left-sided heart failure who get implanted devices to improve the pumping of their hearts may be more likely to develop heart failure on the opposite side of their hearts if they are pre ...

The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of ...

Left ventricular assist devices (LVADs), particularly the latest iterations, can greatly increase functional capacity and quality of life for patients with heart failure, more than a decade’s worth of ...

ANAHEIM, Calif. — A decision-support intervention was associated with improved decision quality among candidates for a left ventricular assist device, according to results from the DECIDE-LVAD trial.

(UPDATED) The HeartWare left ventricular assist device (LVAD) may now be used in the United States as a destination therapy in patients with end-stage heart failure who are not candidates for ...

The FDA approved a new, less invasive surgical technique for the placement of Abbott’s best-selling heart pump, allowing patients to avoid open surgery. The HeartMate 3 left ventricular assist device ...